Project Grant F30MH139336
Award Date 11/1/26
Completion Date 5/7/30
Dollars Obligated $110K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- The National Institute of Mental Health awarded Seattle Children's Research Institute $895,798 on August 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized hybrid implementation-effectiveness trial evaluating motivational interviewing enhanced cognitive behavior therapy for adults with ADHD. The trial will test combined CBT+MI against CBT alone, enrolling 216 adults with ADHD across 72 independent telepsychology providers licensed as psychologists with...
- The National Institute on Drug Abuse awarded Thomas Jefferson University $279,294 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to examine how ADHD stimulant treatment patterns affect substance use outcomes in adolescents. The research leverages longitudinal data from the Adolescent Brain Cognitive Development (ABCD) Study to investigate the causal relationship between different stimulant treatment trajectories—continuous, intermittent, and...
- The National Institute of Mental Health awarded Florida International University $809,160 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test novel approaches to supporting elementary school students with ADHD within multi-tiered systems of support (MTSS). The project, titled "Novel Approaches to Supporting Students with ADHD in Multi-Tiered Systems of Support," addresses behavioral difficulties in the classroom that inhibit...
- The National Institute of Mental Health awarded Cincinnati Children's Hospital Medical Center $820,196 on March 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct observational and mechanistic research on circadian misalignment in adolescents with attention-deficit/hyperactivity disorder (ADHD). The project investigates how the timing mismatch between adolescents' internal circadian phase and early school start times affects attention and functional outcomes in...
- The National Institute of Mental Health awarded the University of Southern California $751,034 on August 6, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support a neuroscience research project examining how the brain processes uncertainty in noisy, dynamically changing environments. The project, titled "Unraveling Neural Mechanisms Underlying Learning in a Noisy, Dynamically Changing World," investigates computational and neural mechanisms by which the brain...
- The National Institute of Mental Health awarded The University of Kentucky Research Foundation $2,695,895 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study examining the relationship between circulating estrogen levels and ADHD symptoms, cognitive performance, and affective outcomes in adolescent girls across the menstrual cycle. The study will recruit 100 adolescents under age 18 at later pubertal stages with regular menstrual...
- The National Institute of Mental Health awarded the University of Southern California $1.105 million on August 7, 2026, under the Mental Health Research Grants program (CFDA 93.242) to establish a global framework for harmonized functional MRI analysis in psychiatry. The project will harmonize resting-state fMRI datasets across eight psychiatric and neurodevelopmental disorders—schizophrenia, bipolar disorder, post-traumatic stress disorder, major depression disorder, obsessive compulsive...
- The National Institute of Mental Health awarded University of California, Los Angeles $764,785 under the Mental Health Research Grants program (CFDA 93.242) on July 16, 2026, to investigate context-dependent disease mechanisms in neurodevelopmental disorders, specifically the 16p11.2 chromosomal deletion (16PDEL) implicated in autism, intellectual disability, and ADHD. The project will use a proprietary in vitro human stem cell platform called the Cell Village to conduct high-throughput...
- The National Institute of Mental Health awarded the University of California, Los Angeles $444,845 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2026, to conduct a two-year study examining intra-individual determinants of neural oscillation phenomena. The funded research deploys multi-sensor measurements to concurrently capture objective measures of arousal (heart rate, heart rate variability, galvanic skin response, pupil metrics), motor activation (body, limb,...
- The National Institute of Mental Health awarded the University of Southern California $249,000 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support basic research on the dysbindin-1–SRC–GluN2A pathway as a mechanism to restore glutamate receptor function in schizophrenia. The research employs a cell-circuit-behavior approach to assess how dysbindin-1 and SRC regulate N-methyl-D-aspartate receptor (NMDAR) signaling and working memory. The study will measure...